Jane Street’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Buy
+19,500
New +$243K ﹤0.01% 9481
2025
Q4
– Sell
-13,000
Closed -$156K – 12025
2025
Q3
$156K Buy
+13,000
New +$137K ﹤0.01% 9857
2025
Q1
– Sell
-20,000
Closed -$161K – 10289
2024
Q4
$161K Buy
+20,000
New +$184K ﹤0.01% 8545

Other funds holding ORIC

Jane Street's ORIC Position: Q3 2026 in Review

Jane Street opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 49,296 shares worth $664K. The stake represents ﹤0.01% of the portfolio and ranks #7373 among its holdings. This is a return to the name: Jane Street previously reported a position in ORIC as recently as Q1 2026.

Jane Street first reported a position in ORIC in Q2 2020 and has held it in 13 quarters since. The position peaked at $2M in Q4 2025. 201 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Jane Street held 49,296 shares of Oric Pharmaceuticals worth $664K as of Q3 2026.
  • Oric Pharmaceuticals was a new Jane Street position in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7373 holding.
  • Jane Street first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • Jane Street's Oric Pharmaceuticals position peaked at $2M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.